Pubfacts - Scientific Publication Data
  • Categories
  • Journals
  • ->
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

The BAFF-Interacting receptors of chickens.

Authors:
Shalini K Reddy Tuanjun Hu Rao Gudivada Karen A Staines Kathryn E Wright Lucy Vickerstaff Sonja Kothlow Lawrence G Hunt Colin Butter Bernd Kaspers John R Young

Dev Comp Immunol 2008 11;32(9):1076-87. Epub 2008 Mar 11.

Institute for Animal Health, Compton, Newbury, Berkshire RG20 7NN, UK.

The TNF superfamily cytokine BAFF has crucial roles in homoeostatic regulation of B cell populations in mammals. Similar effects on peripheral B cells have been reported for chicken as for mammalian BAFF. Unlike mammalian BAFF, chicken BAFF is produced by B cells, implying an autocrine loop and consequent differences in regulation of B cell homoeostasis. Understanding of these mechanisms requires investigation of BAFF-binding receptors in chickens. We identified and characterised chicken receptors BAFFR and TACI, but found that the gene encoding the third BAFF-binding receptor, BCMA, was disrupted, implying differences in mechanisms for maintenance of long-lived antibody responses. A BAFFR-Ig fusion protein expressed in vivo lowered B cell numbers, showing that it was functional under physiological conditions. We found changes in the ratio of BAFFR and TACI mRNAs in the bursa after hatch that may account for the altered requirements for B cell survival at this stage of development.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dci.2008.02.004DOI Listing
July 2008

Publication Analysis

Top Keywords

mammalian baff
8
regulation cell
8
receptors chickens
8
baffr taci
8
receptor bcma
4
cell homoeostasis
4
baff-binding receptor
4
homoeostasis understanding
4
third baff-binding
4
bcma disrupted
4
disrupted implying
4
maintenance long-lived
4
mechanisms maintenance
4
differences mechanisms
4
implying differences
4
encoding third
4
gene encoding
4
baff-binding receptors
4
investigation baff-binding
4
requires investigation
4

Similar Publications

B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE).

Authors:
Tamara Möckel Fabio Basta Julia Weinmann-Menke Andreas Schwarting

Autoimmun Rev 2021 Feb 14;20(2):102736. Epub 2020 Dec 14.

Department of Internal Medicine I, Division of Rheumatology and Clinical Immunology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; Acura Rheumatology Center Rhineland Palatinate, Bad Kreuznach, Germany.

The B cell activating factor (BAFF), or B lymphocyte stimulator (BLyS), is a B cell survival factor which supports autoreactive B cells and prevents their deletion. BAFF expression is closely linked with autoimmunity and is enhanced by genetic alterations and viral infections. Furthermore, BAFF seems to be involved in adipogenesis, atherosclerosis, neuro-inflammatory processes and ischemia reperfusion (I/R) injury. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.

Authors:
Chaoheng Yu Shuang Chen Bailing Zhou Hailong Zhang Xiaoqing Su Yi Luo Li Yang

Mol Immunol 2021 01 27;129:1-11. Epub 2020 Nov 27.

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, Sichuan, China. Electronic address:

Abnormal B cells, which produce antibodies against self-antigens, play a key role in the pathogenesis of autoimmune diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). B-cell activating factor (BAFF) is closely associated with abnormal B cells and participates in B cell-mediated autoimmune diseases; thus, neutralizing BAFF is an effective method for treating these diseases. Our group designed a novel fusion protein, BAFF-Trap, that contains the BAFF-binding domains of two BAFF receptors (TACI and BAFF-R) and the Fc domain of human IgG1. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Alteration of BAFF and APRIL in the cerebrospinal fluid based on the therapeutic response in primary central nervous system B-cell lymphoma.

Authors:
Junji Ikeda Yasuhiro Shimojima Tsuneaki Yoshinaga Minori Kodaira Sayaka Nishina Kiyoshi Ito Yoshiki Sekijima

J Clin Neurosci 2020 Nov 28;81:72-75. Epub 2020 Sep 28.

Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.

We evaluated the cerebrospinal fluid (CSF) levels of the B-cell activating factor of the tumor necrosis factor family (BAFF) and A proliferation-inducing ligand (APRIL) in two cases of primary central nervous system B-cell lymphoma (PCNSBL) before and after treatment. One patient achieved clinical remission, and demonstrated decrease in the CSF levels of both BAFF and APRIL after treatment. Meanwhile, the other patient with insufficient therapeutic response showed increase in the BAFF levels despite decrease in APRIL levels. Read More

View Article and Full-Text PDF
November 2020
Similar Publications

Ianalumab (VAY736) in primary Sjögren's syndrome: assessing disease activity using multi-modal ultrasound.

Authors:
Torsten Diekhoff Thomas Fischer Quirino Schefer Maximilian Georg Posch Thomas Dörner Didier Laurent Yue Li Frank D Wagner Stephen John Oliver

Clin Exp Rheumatol 2020 Jul-Aug;38 Suppl 126(4):228-236. Epub 2020 Oct 23.

Novartis Pharma AG, Basel, Switzerland.

Objectives: To apply serial ultrasound (US) assessments to show effects of ianalumab (anti-BAFF-R monoclonal antibody) on inflamed salivary glands of patients with primary Sjögren's syndrome (pSS).

Methods: In a single-centre, 24-week double-blind study (NCT02149420), 27 pSS patients of moderate-to-severe activity were randomly assigned to receive a single i.v. Read More

View Article and Full-Text PDF
October 2020
Similar Publications

Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.

Authors:
Tianle Zhan Baoli Wang Jiayao Fu Yanxiong Shao Lei Ye Huan Shi Lingyan Zheng

Phytomedicine 2021 Jan 13;80:153381. Epub 2020 Oct 13.

Department of Oral Surgery, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research Center of Oral Disease, Shanghai, China; Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai, China. Electronic address:

Background: Hyperactivation of B cells by activators has been demonstrated to play a central role in the pathogenesis of Sjögren's syndrome (SS). In this study, we found that artesunate (ART) can attenuate BAFF-induced B cell hyperactivation and SS-like symptoms in NOD/Ltj mice.

Purpose: To determine the efficacy of ART in attenuating SS-like symptoms in vivo and explore the underlying mechanism in vitro. Read More

View Article and Full-Text PDF
January 2021
Similar Publications
Get 20% Off Journals at LWW.com
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap